Clinical trial
Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy.
NCT03228108 · Radboud University Medical Center, Other · Completed
Key facts
| NCT number | NCT03228108 |
|---|---|
| Title | Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy. |
| Official title | The Effect of Rectal Swab Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy on Infectious Complications and Cost of Care: A Randomized Controlled Trial in the Netherlands. |
| Acronym | pro-SWAP |
| Lead sponsor | Radboud University Medical Center, Other |
| Collaborators | ZonMw: The Netherlands Organisation for Health Research and Development |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Complication, Infection, Prostate Cancer |
| Intervention type | Drug |
| Interventions | Ciprofloxacin, Trimethoprim/Sulfamethoxazole, Fosfomycin, Pivmecillinam/augmentin |
| Enrollment | 1,538 |
| Start date | Apr 3, 2018 |
| Primary completion | Sep 26, 2021 |
| Completion | Sep 26, 2021 |
| First posted | Jul 24, 2017 |
| Last update posted | May 10, 2022 |
| Countries | Netherlands |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: